What is Rilpivirine-Tenofovir-Emtricitabine?

Category: Prescription Drugs

Most popular types: Complera Eviplera Odefsey

false

The antiretroviral drugs rilpivirine, tenofovir, and emtricitabine, and are combined to be taken as one tablet once a day. It may be prescribed for use alone as a complete treatment option or in combination with other antiretroviral medications.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
5
Mild
2
None
16

Commonly reported side effects and conditions associated with Rilpivirine-Tenofovir-Emtricitabine

Side effect Patients
Diarrhea 2
Acid reflux 1
Burning nerve pain in right foot 1
Erectile dysfunction 1
Fatigue 1
Gastrointestinal problems 1

Show all 12 reported side effects

Dosages

Based on patients currently taking Rilpivirine-Tenofovir-Emtricitabine

Dosage Patients
1 daily 2
1 tablet(s) daily 1
200-25-25 mg daily 1
600 mg daily 1

Why patients stopped taking Rilpivirine-Tenofovir-Emtricitabine

Multiple reasons could be selected

Reason Patients
Side effects too severe 4
Other 3
Doctor's advice 1
Personal research 1
See all 7 patients who've stopped taking Rilpivirine-Tenofovir-Emtricitabine

Duration

Currently taking Rilpivirine-Tenofovir-Emtricitabine

Duration Patients
1 - 2 years 1
2 - 5 years 1
5 - 10 years 3

Stopped taking Rilpivirine-Tenofovir-Emtricitabine

Duration Patients
1 - 6 months 1
6 months - 1 year 3
1 - 2 years 2
2 - 5 years 1
Adherence
Adherence Evaluations
Always 17
Usually 6
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 2
Somewhat hard to take 2
A little hard to take 8
Not at all hard to take 11
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 0
$50-99 2
$25-49 2
< $25 11
Not specified 6

What people switch to and from

Patients started taking Rilpivirine-Tenofovir-Emtricitabine after stopping:

Treatment Patients
Efavirenz-Emtricitabine-Tenofovir (Atripla) 5
Rilpivirine-Tenofovir-Emtricitabine (Complera) 2

Patients stopped taking Rilpivirine-Tenofovir-Emtricitabine and switched to:

Treatment Patients
Rilpivirine-Tenofovir-Emtricitabine (Complera) 2
Cobicistat-elvitegravir-emtricitabine-tenofovir alafenamide (Genvoya) 1
Dolutegravir (Tivicay) 1
Efavirenz-Emtricitabine-Tenofovir (Atripla) 1
Emtricitabine-Tenofovir (Truvada) 1

Show all 6 treatments patients report switching to

Last updated:

2 patient evaluations for Rilpivirine-Tenofovir-Emtricitabine

Sep 4, 2015 (Started Jan 14, 2015)

  • Effectiveness
    Can't tell (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Usually
  • Burden
    Very hard to take
Dosage: 1 tablet(s) Daily
Cost: < $25 monthly

  • 0 helpful marks

Mar 20, 2015 (Started Jun 21, 2014)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Somewhat hard to take
Dosage: 1 capsule(s) Daily
Advice & Tips: taking Complera(US)/Eviplera(EU) needs an adequate volume/calories mix in food: i decided to have a rich breakfast (>500 calories) I switched to Complera/Eviplera due to persisting morning dizzines after efavirenz: the result was great!
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for Rilpivirine-Tenofovir-Emtricitabine